Biomarkers for evaluation of clinical outcomes of hemodiafiltration

Blood Purification

Volumn 35, Issue , 2013, Pages 64-68

  Sakurai, Kenji ^a  

^a Hashimoto Clinic   (Japan)

Author keywords

Hemodiafiltration; Removal rate; Restless legs syndrome; Uremic toxins; 1 Microglobulin; 2 Microglobulin

Indexed keywords

ALBUMIN; ALPHA 1 MICROGLOBULIN; BETA 2 MICROGLOBULIN; PROLACTIN;

ARTICLE; ARTIFICIAL KIDNEY; BLOOD FILTER; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIALYSIS EQUIPMENT AND SUPPLIES; DIFFUSION; HEMODIAFILTER; HEMODIAFILTRATION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MOLECULAR WEIGHT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; THERMODYNAMICS;

EID: 84874752593     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000346364     Document Type: Article

References (21)

1. Canaud B: The early years of on-line HDF: how did it all start? How did we get here? in Krick G, Ronco C (eds): On-Line Hemodiafiltration: The Journey and the Vision. Contrib Nephrol. Basel, Karger, 2011, vol 175, pp 93-109.
2. Tattersall J: Clearance of beta-2-microglobulin and middle molecules in haemodiafiltration; in Ronco C, Canaud B, Aljama P (eds): Hemodiafiltration. Contrib Nephrol. Basel, Karger, 2007, vol 158, pp 201-209.
3. Canaud B, Chenine L, Renaud S, et al: Optimal therapeutic conditions for online hemodiafiltration; in Kawanishi H, Yamashita AC (eds): Hemodiafiltration-A New Era. Contrib Nephrol. Basel, Karger, 2011, vol 168, pp 28-38.
4. Pedrini LA, De Cristofaro V, Comelli M, et al: Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrol Dial Transplant 2011; 26: 2617-2624.
5. Ronco C, Cruz D: Hemodiafiltration history, technology, and clinical results. Adv Chronic Kidney Dis 2007; 14: 231-243.
6. Nakai S, Iseki K, Tabei K, et al: Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 2001; 38:S212-S216.
7. Locatelli F, Altieri P, Andrulli S, et al: Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. Nephrol Dial Transplant 2012; 27: 3594-3600.
8. Gejyo F, Yamada T, Odani S, et al: A new form of amyloid protein associated with chronic hemodialysis was identified as beta2-microglobulin. Biochem Biophys Commun 1985; 129: 1-9.
9. Geijo F, Narita I: current clinical and pathogenetic understanding of beta2-m amyloidosis in long term hemodialysis patients. Nephrology (Carlton) 2003; 8(suppl):S45-S49.
10. Okuno S, Ishimura E, Kohno K, et al: Serum beta2-microgobulin level is a significant predictor of mortality in maintenance haemodialysis patients. Nephrol Dial Transplant 2009; 24: 571-577.
11. Furuya R, Kumagai H, Takahasi M, et al: Ultrapure dialysis reduces level of beta2-microglobulin and pentosidine hemodialysis patients. Blood Purif 2005; 23: 311-316.
12. Ahrenholz PG, Winkler RE, Michelsen A, et al: Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clin Nephrol 2004; 62: 21-28.
13. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C: International Restless Legs Syndrome Study Group: Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-132.
14. Shinzato T, Maeda K: Push/pull hemodiafiltration; in Ronco C, Canaud B, Aljama P (eds): Hemodiafiltration. Contrib Nephrol. Basel, Karger, 2007, vol 158, pp 169-176.
15. Kazama JJ, Maruyama H, Gejyo F: Reduction of circulating beta2-microglobulin level for the treatment of dialysis-related amyloidosis. Nephrol Dial Transplant 2001; 16(suppl 4):31-35.
16. Heegaard NH: β 2-Microglobulin: from physiology to amyloidosis. Amyloid 2009; 16: 151-173.
17. Gejyo F, Homma N, Suzuki Y, et al: Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med 1986; 314: 585-586.
18. Akihiro CY, Kenji S: Choice of dialyzers for HDF; in Kawanishi H, Yamashita AC (eds): Hemodiafiltration-A New Era. Contrib Nephrol. Basel, Karger, 2011, vol 168, pp 146-152.
19. Tomo T, Matsuyama M, Nakata T, et al: Effect of high fiber density ratio polysulfone dialyzer on protein removal. Blood Purif 2008; 26: 347-353.
20. Tomo T, Matsuyama K, Nasu M: Effect of hemodiafiltration against radical stress in the course of blood purification. Blood Purif 2004; 22(suppl 2):72-77.
21. Vanholder R, Schepers E, Pletinck A, et al: An update on protein-bound uremic retention solutes. J Ren Nutr 2012; 22: 90-94.